REFILE-Novartis says Votubia receives EU approval for new indication
ZURICH, Jan 31 (Reuters) - Novartis has broadened the indications for its Votubia drug, the company said on Tuesday, when the European Union approved its use to treat refractory partial-onset seizures in patients with tuberous sclerosis complex. [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: Votubia, complex, tuberous sclerosis, patients, seizures, partial-onset, treat refractory, approved, Union, European, on Tuesday, company, indications, broadened the, Novartis, (Reuters), ZURICH, indication, approval, receives, REFILE-Novartis
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/NEib5yaz6js/novartis-votubia-idUSFWN1FL01Y